Navigation Links
VIA Pharmaceuticals Presents Data at American Heart Association Meeting Showing VIA-2291 Significantly Reduces Inflammation in Preclinical Model of Atherosclerosis
Date:11/6/2007

SAN FRANCISCO and ORLANDO, Fla., Nov. 6 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, today presented data showing that VIA-2291 significantly inhibited vascular inflammation in a mouse model of atherosclerosis. VIA-2291, the company's lead drug candidate, is a potent, selective and reversible inhibitor of 5-lipoxygenase (5-LO), which is a key enzyme in the biosynthesis of leukotrienes (important mediators of inflammation involved in the development and progression of atherosclerosis).

The data were presented at the Inflammation and Adhesion Molecules II session at the American Heart Association Scientific Sessions 2007 in Orlando, FL (poster: B138).

"These data further validate our human clinical trial program with VIA-2291," said Larry Cohen, Ph.D., president and chief executive officer of VIA. "By targeting this key pathway in vascular inflammation, we believe VIA-2291 may have the potential to reduce the major adverse cardiac events that occur as a result of the rupture of unstable plaque. We are encouraged that these data support VIA-2291 as a potential, powerful anti-inflammatory compound for the vascular system."

Atherosclerosis is the result of chronic inflammation and the buildup of plaque in arterial blood vessel walls. Research in both humans and mice has noted abundant expression of 5-LO co-localizing with macrophages in aortic lesions. These cells are often implicated in vascular inflammation in atherosclerosis.

The study used mice that were genetically modified to develop atherosclerosis. A team of researchers headed by Thomas Quertermous, M.D., chief of the
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading ... announced today that it has been selected by the Beijing ... a supplier of the seasonal influenza vaccine to the citizens ... The Beijing CDC plans to order a minimum of 1.2 ... four domestic vaccine manufacturers for its vaccination campaign. Each manufacturer ...
(Date:7/22/2014)... DALLAS , July 22, 2014 /PRNewswire-iReach/ -- ... the basis of application, technology, portability, product, end ... expected to register the highest growth rate in ... forecast period. This high growth is attributed to ... cancer. Chest imaging accounted for the largest share ...
(Date:7/22/2014)... Research and Markets has announced ... Equipment, by Reagent, by Application - Global Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals are pharmaceutical ... of the most important and widely used techniques for ... of the cell culture market in 2013. Growth in ...
Breaking Medicine Technology:Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu 2Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 2Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 3Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 4Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 5Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3
... 2011 Reportlinker.com announces that a new ... catalogue: Global Hospital Information ... http://www.reportlinker.com/p0703211/Global-Hospital-Information-Systems-HIS-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=e-Healthc This report analyzes ... (HIS) in US$ Millions by the following ...
... 12, 2011 Global Telecom Testing (GTT) ... international ,reach and response, market research service that ... collection. GTT,s Professional Services offers a unique competitive ... GTT,s Professional Services eliminate the need ...
Cached Medicine Technology:Global Hospital Information Systems (HIS) Industry 2Global Hospital Information Systems (HIS) Industry 3Global Hospital Information Systems (HIS) Industry 4Global Hospital Information Systems (HIS) Industry 5Global Hospital Information Systems (HIS) Industry 6Global Hospital Information Systems (HIS) Industry 7Global Hospital Information Systems (HIS) Industry 8Global Hospital Information Systems (HIS) Industry 9Global Hospital Information Systems (HIS) Industry 10Global Hospital Information Systems (HIS) Industry 11Global Hospital Information Systems (HIS) Industry 12Global Hospital Information Systems (HIS) Industry 13Global Hospital Information Systems (HIS) Industry 14Global Hospital Information Systems (HIS) Industry 15Global Hospital Information Systems (HIS) Industry 16Global Hospital Information Systems (HIS) Industry 17Global Hospital Information Systems (HIS) Industry 18Global Hospital Information Systems (HIS) Industry 19Global Hospital Information Systems (HIS) Industry 20Global Hospital Information Systems (HIS) Industry 21Global Hospital Information Systems (HIS) Industry 22Helping Companies Reach Global Markets 2
(Date:7/23/2014)... Online medical service provider MeMD has appointed ... Dr. Lorenzo joins the MeMD executive team with over ... a part of this remote treatment model, telemedicine. This is ... in medical school, that someday we could treat people across ... here and it hasn't been that long,” says Dr. Lorenzo. ...
(Date:7/23/2014)... GA (PRWEB) July 23, 2014 ... manufacturer located in Lawrenceville, Georgia, welcomed Andreas von Uexkull ... his tour of the U.S. von Uexkull, a top ... an extended tour of the U.S. to bring awareness ... Trans-Atlantic Trade and Investment Partnership (TTIP). , As ...
(Date:7/23/2014)... New York (PRWEB) July 23, 2014 ... the “National Plan to Address Alzheimer’s Disease” at the ... and the Alzheimer’s Foundation of America (AFA) ... the scope of the Alzheimer’s crisis, and the need ... services specific to those localities. , The white ...
(Date:7/23/2014)... July 23, 2014 Picnic Lunches, Residents of ... including outdoor concerts and festivals, while still dining on the ... to concerts in the park or to the beach or ... a great meal while they’re out,” said Brian Hughes, director ... that the residents are just loving.” , Hagopian, the executive ...
(Date:7/23/2014)... childbirth and post delivery may reduce the risk of ... perinatal psychiatrist, in a July 23 editorial in ... based on a new Chinese study that found women ... vaginal delivery had a much lower risk for postpartum ... "Maximizing pain control in labor and delivery with your ...
Breaking Medicine News(10 mins):Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 2Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 3Health News:Swedish Official Tours PartnerTech’s U.S. Facility 2Health News:Swedish Official Tours PartnerTech’s U.S. Facility 3Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 2Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 3Health News:Chicago’s The Clare Retirement Community Announces New Summertime Culinary Programs 2Health News:Controlling childbirth pain tied to lower depression risk 2
... Mich., July 15 Webahn Inc. announces,the launch ... This new system makes it affordable for small ... Send2Press.com/mediaboom/08-0715-Capzule_72dpi.jpg), The launch of Capzule.com comes at ... New England Journal of Medicine that reported many ...
... Huntington,s disease, research by integrating internal knowledge and curated ... ... REDWOOD CITY, Calif., July 15 Ingenuity Systems, the,leading provider ... non-profit organization focused on discovering and,developing drugs to treat Huntington,s disease, ...
... relationships have some degree of,conflict or distance. The majority ... relationships that end in heartbreak are countless., In ... states that when a,relationship isn,t working, there will always ... is creating the problem., Bill Ferguson says, "This ...
... improving cash flow and financial resources, including Social Security Disability Insurance ... ... Belleville, IL (Vocus) July 15, 2008 -- Someone can ... happens or from a gradual onset of chronic illness. Then the ...
... Obesity expert Sanford Siegal, D.O., M.D., known to generations as the ... 9th , ... McLean, VA (PRWEB) July 15, 2008 ... Dr. Siegal's® COOKIE DIET™ hunger-controlling foods and operator of seven ...
... his proven and simple strategies in Business, Employee Management, Marketing and ... with India's obvious human and economical challenges, he will lend his ... , ... Los Angeles, CA. (PRWEB) July 15, 2008 ...
Cached Medicine News:Health News:Electronic Medical Records Are No Longer Limited to Physicians with Deep Pockets 2Health News:Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform 2Health News:Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform 3Health News:Bill Ferguson's New Book, Get Your Power Back: It Only Takes One Person to Heal a Difficult Relationship 2Health News:Key Steps Can Help with Financial Impact of Disability 2Health News:Key Steps Can Help with Financial Impact of Disability 3Health News:Key Steps Can Help with Financial Impact of Disability 4Health News:Eighth Dr. Siegal's COOKIE DIET Retail Location Opens August 1st at Tysons Corner Center Near Washington, DC 2Health News:Eighth Dr. Siegal's COOKIE DIET Retail Location Opens August 1st at Tysons Corner Center Near Washington, DC 3Health News:The Five Biggest Marketing Mistakes Made By Medical Offices and Small Businesses 2
... Millipore has developed a range ... to match specific water quality requirements. ... systems is designed to specifically target ... as HPLC, molecular biology and ICP-MS. ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... Millipore has developed a range ... to match specific water quality requirements. ... systems is designed to specifically target ... as HPLC, molecular biology and ICP-MS. ...
... Millipore has developed a range ... to match specific water quality requirements. ... systems is designed to specifically target ... as HPLC, molecular biology and ICP-MS. ...
Medicine Products: